July 16, 2020
Stand Up To Cancer Announces New Research and Education Effort Focused on Improving Health Equity for Underserved Lung Cancer Patients
Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities.
Read MoreJune 1, 2020
Convenient Spit Test Helps Women Assess Cancer Risk From the Comfort of Their Own Homes
Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who might have a genetic risk often don’t get tested.
Read MoreMay 26, 2020
Stand Up To Cancer Hails FDA Approval of Olaparib for Advanced Prostate Cancer
A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Read MoreMay 20, 2020
Jaime Camil Joins Cancer Survivors in New PSA for Stand Up To Cancer® to Encourage Hispanic Participation in Cancer Clinical Trials
Actor and Stand Up To Cancer (SU2C) Ambassador Jaime Camil has joined forces with cancer survivors in a new public service announcement (PSA) campaign to raise awareness with the Hispanic community about cancer clinical trials.
Read MoreApril 29, 2020
Stand Up To Cancer Hails FDA Approval of Encorafenib + Cetuximab Combination for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Stand Up To Cancer (SU2C) welcomed the recent Food and Drug Administration (FDA) approval this month of encorafenib in combination with cetuximab for patients with advanced BRAF-mutated colorectal cancer.
Read MoreApril 27, 2020
Stand Up To Cancer Funded Research To Be Presented During The AACR Virtual Meeting 1 – April 27-28, 2020
Stand Up To Cancer® (SU2C)-supported research will be presented during the American Association for Cancer Research Annual (AACR) Virtual Meeting 10 from April 27th to 28th.
Read MoreMarch 30, 2020
New COVID-19 symptom reasearch app recruiting millions of Americans, including healthcare professionals, cancer patients and survivors, to beat the disease
As the COVID-19 coronavirus pandemic grips the US, a new free app is helping to track the onset and progression of symptoms of millions across the nation. The app will help identify those at risk sooner, and help slow the outbreak of the disease. Information about those who remain symptom-free will also support better understanding of COVID-19.
Read MoreMarch 5, 2020
The Pancreatic Cancer Collective Extends Four Research Teams in $16 Million Push for New Therapies
The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded additional funding of up to $16 million to four teams of top researchers as part of its “New Therapies Challenge Grants,” the American Association for Cancer Research (AACR), Scientific Partner of SU2C, announced today.
Read MoreJanuary 28, 2020
Stand Up To Cancer Awards 2020 Laura Ziskin Prize in Translational Research To Drs. Leisha A. Emens and Xiang Zhang
Stand Up To Cancer (SU2C) has awarded the 2020 Laura Ziskin Prize in Translational Research to two highly respected clinical investigators who will come together in a novel collaboration between leaders in breast cancer immuno-oncology and tumor immunology for research to further the availability of immune checkpoint inhibitors for breast cancer patients. Dr. Leisha A. Emens, MD, PhD of UPMC Hillman Cancer Center, and Dr. Xiang Zhang, PhD of Baylor College of Medicine will share a $250,000 grant for their year-long research project which was awarded today at the 2020 SU2C Scientific Summit in Santa Monica.
Read MoreJanuary 27, 2020
Stand Up To Cancer Announces International Team on Early Detection of Gastric Cancer, World’s 3rd Leading Cause of Cancer Death
Stand Up To Cancer (SU2C) announced today that an international team of experts will take a new approach to fighting the world’s third-leading cause of cancer death -- stomach (or gastric) cancer.
Read More